Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone-iodine plus glycyrrhizic acid nasopharyngeal spray and glycyrrhizic acid syrup for early COVID-19
PACTR202101875903773Completed
- Sponsor
- Hazem Elsersy
- Start
- Jan 2021
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of povidone-iodine and glycyrrhizin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Hazem Elsersy. Started Jan 2021; status: completed.
02
Drugs
povidone-iodineglycyrrhizin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202101875903773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202101875903773.